Does PSADT after radical prostatectomy correlate with overall survival?-A report from the SEARCH database group

Urology

Volumn 77, Issue 1, 2011, Pages 149-153

  Teeter, Anna E ^a   Presti Jr , Joseph C ^a   Aronson, William J ^a   Terris, Martha K ^a   Kane, Christopher J ^a   Amling, Christopher L ^a   Freedland, Stephen J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CORRELATIONAL STUDY; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN DOUBLING TIME; PROSTATECTOMY; TERTIARY HEALTH CARE;

DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 78650882949     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.04.071     Document Type: Article

References (20)

1. J.G. Trapasso, J.B. deKernion, and R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
2. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
3. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality J Clin Oncol 25 2007 1765 1771
4. P.C. Albertsen, J.A. Hanley, and D.F. Penson Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation J Urol 171 2004 2221 2225
5. R.K. Valicenti, M. DeSilvio, and G.E. Hanks Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02 Int J Radiat Oncol Biol Phys 66 2006 1064 1071
6. A.V. D'Amico, J.W. Moul, and P.R. Carroll Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy J Natl Cancer Inst 95 2003 1376 1383
7. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
8. A.A. Jacinto, A.B. Fede, and L.A. Fagundes Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy Radiol Oncol 2 2007 8
9. A.K. Lee, L.B. Levy, and R. Cheung Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy Int J Radiat Oncol Biol Phys 63 2005 456 462
10. J.F. Ward, H. Zincke, and E.J. Bergstralh Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy J Urol 172 2004 2244 2248
11. A.J. Stewart, H.I. Scher, and M.H. Chen Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure J Clin Oncol 23 2005 6556 6560
12. R.J. Hamilton, W.J. Aronson, and J.C. Presti Jr Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database Cancer 110 2007 2202 2209
13. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
14. D.M. Moreira, L.L. Banez, and J.C. Presti Jr Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database BJU Int 105 2009 28 33
15. A.E. Teeter, L.L. Banez, and J.C. Presti Jr What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group J Urol 180 2008 1980 1985
16. F.R. Schroeck, W.J. Aronson, and J.C. Presti Jr Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int 103 2009 603 608
17. Available from: www.clinicaltrials.gov.
18. G.D. Grossfeld, D.M. Latini, and T. Downs Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol 168 2002 2510 2515
19. Jayachandran J, Aronson WJ, Terris MK, et al. Diabetes and outcomes after radical prostatectomyare results affected by obesity and race? Results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. In press.
20. Moreira DM, Antonelli J, Presti JC. Jr, et al. Association of cigarette smoking with time to biochemical recurrence after radical prostatectomy: results from the SEARCH database. Submitted.